SCHEMBL5163392

SCHEMBL5163392

COc1ccccc1N=S(=O)=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 3/20 0.48
▸ CA2 P00918 3/20 0.48
▸ CA7 P43166 2/20 0.48
▸ CA9 Q16790 2/20 0.48
▸ CA12 O43570 1/20 0.48
▸ CA4 P22748 1/20 0.48
▸ CA14 Q9ULX7 1/20 0.48
▸ ALDH1A1 P00352 6/20 0.43
▸ L3MBTL1 Q9Y468 2/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ KMT2A Q03164 3/20 0.42
▸ NOS3 P29474 2/20 0.41
▸ NOS1 P29475 2/20 0.41
▸ NOS2 P35228 2/20 0.41
▸ GRIN2D O15399 1/20 0.41
▸ GRIN3B O60391 1/20 0.41
▸ GRIN1 Q05586 1/20 0.41
▸ GRIN2A Q12879 1/20 0.41
▸ GRIN2B Q13224 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4409583 0.78 KMT2A (0.46) ALDH1A1L3MBTL1MAPK1HTTKMT2A
SCHEMBL14920013 0.77 IDO1 (0.47) CA1CA2CA7CA9CA12
SCHEMBL944259 0.76 CA1 (0.55) CA1CA2CA7CA9CA12
SCHEMBL1405475 0.75 CA1 (0.60) CA1CA2CA7CA9CA12
SCHEMBL1405477 0.75 CA1 (0.60) CA1CA2CA7CA9CA12
SCHEMBL55260 0.75 CA1 (0.60) CA1CA2CA7CA9CA12
SCHEMBL11317412 0.75 ACHE (0.50) ALDH1A1L3MBTL1MAPK1KMT2AHPGD
SCHEMBL1575877 0.73 CA1 (0.57) CA1CA2CA7CA9CA12
SCHEMBL13185882 0.71 CA1 (0.55) CA1CA2CA7CA9CA12
SCHEMBL3325213 0.71 CA1 (0.55) CA1CA2CA7CA9CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105002256-B Combined-enzyme method, which is split, prepares the pure R- of optically-active(-)The method of tamsulosin 杭州人可生物制品有限公司 2018-02-23 — — CN disclosed
EP-1765332-A2 TRISUBSTITUTED NITROGEN MODULATORS OF TYROSINE PHOSPHATASES Cengent Therapeutics, Inc. (US) 2007-03-28 — — EP disclosed
WO-2006009876-A2 TRISUBSTITUTED NITROGEN MODULATORS OF TYROSINE PHOSPHATASES CENGENT THERAPEUTICS, INC. (US) 2006-01-26 — — WO disclosed
Send feedback